Abstract
Renal metabolic bone disease is a heterogenous group of bone disorders, some delineated as distinct entities, each of which has distinct pathophysiological mechanisms, and other, often interlinked mechanisms, which are incompletely understood (Table 1).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Malluche HH, Faugere M-C. Renal bone disease 1990: An unmet challenge for the nephrologist.Kidney Int1990; 38: 193–211.
Pei Y, Hercz G, Greenwood C, et al. Risk factors for renal osteodystrophy.JBone Miner Res1995; 10: 149–156.
Hutchison A, Whitehouse RW, Boulton HF, et al. Correlation of bone histology with parathyroid hormone, Vitamin D and radiology in end-stage renal disease.Kidney Int1993; 44: 1071–1077.
Malluche HH, Monier-Faugere M-C. The role of bone biopsy in the management of patients with renal osteodystrophy.JAm Soc Nephrol1994; 41: 1631–1642.
Gabay C, Rvedin P, Slosman D, et al. Bone mineral density in patient with end-stage renal disease.Am J Nephrol1993 13: 115–123.
Copley JB, Hui SL, Leapman S, Slemenda CW, Johnston CC. Longitudinal study of bone mass in end-stage renal disease patients: Effects of parathyroidectomy for renal osteodystrophy.J Bone Miner Res1993; 8: 415–422.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Miller, P.D. (1996). Bone Mass in Renal Disease. In: Rosen, C.J. (eds) Osteoporosis. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0221-9_22
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0221-9_22
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-6668-6
Online ISBN: 978-1-4612-0221-9
eBook Packages: Springer Book Archive